Hepatic Impairment Equipment & Supplies
8 equipment items found
Manufactured by:Darnitsa Group based inKyiv, UKRAINE
Antihistamines for systemic use. Doxylamine. Other sleeping pills and sedatives. Hipnos is a soporific drug belonging to the class of ethanolamines from the group of histamine H1-receptor blockers, which has a sedative and M-cholinoblocking action. It reduces the time required for falling asleep, increases the duration and quality of ...
Manufactured by:United Therapeutics Corporation based inSilver Spring, MARYLAND (USA)
Orenitram is a prostacyclin mimetic indicated for treatment of pulmonary arterial hypertension (PAH; WHO Group 1), to delay disease progression and to improve exercise capacity. The studies that established effectiveness included predominately patients with WHO functional class II-III symptoms and etiologies of idiopathic or heritable PAH (66%) or PAH associated with connective tissue disease ...
Manufactured by:Darnitsa Group based inKyiv, UKRAINE
Symbiia® - for treatment of major depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety ...
Manufactured by:RedHill Biopharma Ltd. based inTel-Aviv, ISRAEL
TALICIA is an oral, all-in-one capsule containing omeprazole, amoxicillin, and rifabutin that is indicated for the treatment of Helicobacter pylori infection in ...
Manufactured by:Biomed Lublin S.A. based inLublin, POLAND
Name Of The Medicinal Product; DISTREPTAZA; Streptokinase + Streptodornase; 15000 IU + 1250 IU. Rectal ...
Manufactured by:Eagle Pharmaceuticals, Inc. based inWoodcliff Lake, NEW JERSEY (USA)
Indication: Byfavo is a benzodiazepine indicated for the induction and maintenance of procedural sedation in adults undergoing procedures lasting 30 minutes or ...
Manufactured by:United Therapeutics Corporation based inSilver Spring, MARYLAND (USA)
Adcirca is a phosphodiesterase 5 (PDE-5) inhibitor indicated for the treatment of pulmonary arterial hypertension (PAH)(WHO Group 1) to improve exercise ability. Studies establishing effectiveness included predominately patients with NYHA Functional Class II–III symptoms and etiologies of idiopathic or heritable PAH (61%) or PAH associated with connective tissue diseases ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
Selvigaltin (GB1211) is an orally active galectin-3 small molecule inhibitor with an IC50 value of 12 nM in rabbits, showing anti-tumor activity. Selvigaltin decreases galectin-3 levels in the liver and reduces biomarkers of liver function (AST, ALT, bilirubin), inflammation (cells foci) and fibrosis (PSR, SHG), as well as decreasing the mRNA and protein expression of several key inflammation and ...